Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials

International Journal of Obesity, Published online: 17 July 2023; doi:10.1038/s41366-023-01337-xEfficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials

Source: International Journal of Obesity - July 17, 2023 Category: Eating Disorders & Weight Management Authors: Yasmin Luz Lima de Mesquita Izabela Pera Calvi Isabela Reis Marques Sara Almeida Cruz Eduardo Messias Hirano Padrao Pedro Emanuel de Paula Carvalho Caroliny Hellen Azevedo da Silva Rhanderson Cardoso Filipe Azevedo Moura Vladimir Vitalievich Rafalskiy Source Type: research